Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma:: A case report

被引:12
作者
Pedersen, LO [1 ]
Vetter, CS
Mingari, MC
Andersen, MH
Straten, PT
Bröcker, EB
Becker, JC
机构
[1] Danish Canc Soc, DK-2100 Copenhagen, Denmark
[2] Univ Wurzburg, Dept Dermatol, Wurzburg, Germany
[3] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy
[4] Natl Inst Canc Res, Genoa, Italy
关键词
autoimmunity; cellular; hypopigmentation; immunity; self tolerance;
D O I
10.1046/j.1523-1747.2002.01698.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Selection and activation of T cells is tightly regulated by both antigen-specific receptors and co-receptors to ensure that responses to self antigens are largely avoided. By T cell receptor clonotypic mapping and staining with tetrameric HLA-peptide complexes, we demonstrate the presence of melanocyte differentiation antigen MART-1 specific T cells in the areas of destruction of both neoplastic and normal melanocytic cells in a case of a primary melanoma and its associated hypopigmentation. These self reactive T cells expressed CD94/NKG2 major histocompatibility complex class I specific C-type lectin-like receptors. This family of receptors includes both activating and inhibitory isoforms. Thus, we performed a detailed analysis that revealed the exclusive presence of inhibitory NKG2-A/B receptors in the vitiligo-like leukoderma, whereas both the inhibitory receptors and the activating NKG2-C/E isoforms were present within the tumor. Our data suggest the differential expression of killer inhibitory receptors as a possible mechanism to regulate T cell responses to self antigens.
引用
收藏
页码:595 / 599
页数:5
相关论文
共 32 条
[1]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[2]   Accumulation of identical T cells in melanoma and vitiligo-like leukoderma [J].
Becker, JC ;
Guldberg, P ;
Zeuthen, J ;
Bröcker, EB ;
Straten, PT .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) :1033-1038
[3]  
Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO
[4]  
2-Y
[5]   Early signaling via inhibitory and activating NK receptors [J].
Bléry, M ;
Olcese, L ;
Vivier, E .
HUMAN IMMUNOLOGY, 2000, 61 (01) :51-64
[6]   RECEPTOR-LIGAND INTERACTIONS MEASURED BY AN IMPROVED SPUN COLUMN CHROMATOGRAPHY TECHNIQUE - A HIGH-EFFICIENCY AND HIGH-THROUGHPUT SIZE SEPARATION METHOD [J].
BUUS, S ;
STRYHN, A ;
WINTHER, K ;
KIRKBY, N ;
PEDERSEN, LO .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1243 (03) :453-460
[7]  
Cambiaggi A, 1999, CURR TOP MICROBIOL, V244, P169
[8]  
Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO
[9]  
2-X
[10]   Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages [J].
Diefenbach, A ;
Jamieson, AM ;
Liu, SD ;
Shastri, N ;
Raulet, DH .
NATURE IMMUNOLOGY, 2000, 1 (02) :119-126